Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Like other serotonergic psychedelics, 5-MeO-DiPT is not habit-forming. While limited data exists, tryptamines of this class are not known for their addictiveness or tendency for compulsive use.
The exact lethal dose is unknown. Fatal intoxications have been reported in humans, including at least two deaths associated with rectal administration. Accidental oral overdoses in the 30-100 mg range have reportedly resulted in stronger effects and increased gastrointestinal distress without apparent life-threatening toxicity.
Serotonergic neurotoxicity has been demonstrated in rodent models, with cognitive deficits in spatial navigation, cognitive flexibility, and attention observed following adolescent exposure; effects are described as less severe than those of MDMA, and human relevance remains unclear.
Rhabdomyolysis and acute renal failure have been reported in the context of overdose; this appears to be an acute toxicity concern rather than a chronic use issue.
There is a report of a prolonged delusional state associated with 5-MeO-DiPT. Individuals with a family history of schizophrenia or early onset mental illness should be cautious as psychedelics have been known to trigger latent psychological and mental problems.
5-MeO-DiPT was first synthesized and tested by American chemist Alexander Shulgin, who conducted the initial human trials of the compound in 1975. Shulgin subsequently co-authored a paper with M. F. Carter detailing the synthesis and human psychopharmacology of both 5-MeO-DiPT and its parent…
Listed on Portaria SVS/MS nº 344. Possession, production, and sale are prohibited under national health surveillance regulations.
Controlled substance as of October 2015. Sale, purchase, import, export, and manufacture are prohibited under SFDA regulations.
Banned in December 2014 under government regulations that prohibited over 100 psychoactive substances.
Designated a controlled substance on February 18, 2003 under national drug control legislation.
Classified as a controlled substance under Latvian national drug legislation.
Controlled as a Class A substance since early 2006. Trafficking penalties include imprisonment ranging from 5 to 20 years and caning.
Specifically named as a controlled substance under Verzeichnis E of Swiss narcotics regulations.
Emergency scheduled by the DEA on April 4, 2003, then formally placed into Schedule I of the Controlled Substances Act on September 29, 2004. Manufacturing, possession, buying, selling, and distribution require a DEA license.
Not listed in Canada's schedules of controlled substances under the Controlled Drugs and Substances Act (CDSA) as of available documentation.
Controlled since February 20, 2004. Possession outside of licensed research and medical contexts is prohibited.
Listed in Schedule I of the Betäubungsmittelgesetz (Narcotics Act) since October 10, 2000. Manufacturing, possession, import, export, purchase, sale, and dispensing without license are prohibited.
Prohibited since April 17, 2005 under Japanese drug control laws.
May be treated as a Class C controlled drug under analogue provisions due to structural similarity to DMT.
Classified as a 'health hazard' under Lagen om förbud mot vissa hälsofarliga varor since October 1, 2004 via regulation SFS 2004:696. Sale and possession are prohibited.
Controlled under the Misuse of Drugs Act 1971 as an ether of 5-HO-DiPT, which falls under the tryptamine catch-all clause. Class A substances carry the most severe penalties.
15 sources cited